Download Files:
Tisotumab vedotin
$960 – $2,500
Products Details
Product Description
– Tisotumab vedotin is an antibody-drug conjugate (ADC) targeting tissue factor (TF). Tisotumab vedotin consists of a fully human monoclonal antibody to tissue factor (TF-011) conjugated to Monomethyl Auristatin E (MMAE). Tisotumab vedotin has good antitumor activity and can be used in the research of advanced or metastatic solid tumors[1].
Web ID
– HY-152963
Storage Temperature
– -80°C, protect from light
Shipping
– Dry Ice
Applications
– Cancer-programmed cell death
Molecular Formula
– N/A
References
– [1]Markham A, et al. Tisotumab Vedotin: First Approval. Drugs. 2021 Dec;81(18):2141-2147.
CAS Number
– 1418731-10-8
Molecular Weight
– N/A
Compound Purity
– 99.47
SMILES
– [Tisotumab vedotin]
Clinical Information
– Phase 3
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Antibody-Drug Conjugates (ADCs)
Pathway
– Antibody-drug Conjugate/ADC Related
Product type
– ADC Related
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
